Preclinical evaluation of safety and efficacy of a synthetic compound (MEGR756) and a compound of natural origin (MDN90) with selective activity against cancer stem cells
UGR003 / B-16 / PI
Year of the call
2016
Execution date
01/01/2017 - 31/12/2018
IP
JUAN ANTONIO MARCHAL CORRALES